A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.

A NITI Aayog report outlines India's potential to scale its bioeconomy to USD 691 billion by 2035 and USD 2.6 trillion by ...

Growing interest in CIK cell therapy highlights challenges. Creative Biolabs supports researchers with CAR-CIK ...

Greenwich LifeSciences is a single-asset biotech focused on GLSI-100, an immunotherapy for HER2-positive breast cancer. Learn ...

The Central Bureau of Investigation (CBI), which is probing the NEET-UG 2026 paper leak to identify a network of conspirators ...

Recent developments in the NEET paper leak case reveal that Shivraj Motegaonkar, a coaching centre owner arrested by the CBI, ...

Earlier this month, data analytics and consulting firm GlobalData released a report citing an increasingly widening ...

Following a turbulent funding environment, biotechs are seeking to generate more data earlier to reassure investors.

Cannara Biotech (TSX:LOVE) released third-quarter financial results and hosted an earnings call on Wednesday. Read the ...

The two startups are the third and fourth, respectively, to outline offerings this month and aim to capitalize on momentum ...

For most of 2026, the market's story has mostly been on semiconductors and artificial intelligence. Jim Cramer just told investors to look somewhere else. On his CNBC show, the "Mad Money" host called ...

C11 antibody builds on APOE Christchurch variant biology associated with resilience to Alzheimer’s disease, including effects ...